With just two sessions to go to the end of the year, PharmaMar accumulates a loss in the stock market of almost 24% during this year within the IBEX 35. At a technical level, PharmaMar has closed above 56.10 euros, in the session of the day December 27, which allows estimating a target of 60.27 euros, according to independent analyst Ramón Bermejo. In addition, the stock has described a bullish engulfing pattern, but it has not validated it, as can be seen in the graph.
In Tuesday’s session, he presented an inside bar figure, which he validated from the bottom side. To think about higher increases, you would have to validate it from the upper side, which would be to reach the level of 57.01 euros.
Access our professional trading service here.